Delivery Order SPE2DB22D1017-SPE2DB25FE8JT

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,919.81 firm fixed price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. The contract has a completion date of January 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,336.09 firm fixed-price delivery order contract is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,239.97 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of February 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,593.38 Firm Fixed Price delivery order is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a prescription medication. The contract has an ultimate completion date of September 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,069.39 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of January 9, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,512.01 firm fixed-price delivery order is for the supply of Micardis HCT 40-12.5 mg tablets, a medication used to treat hypertension. The contract has an ultimate completion date of October 28, 2022 and was awarded on October 27, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,228.52 firm-fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication, with a performance period ending on March 1, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,599.04 fixed-price delivery order is for MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of November 21, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.87 delivery order contract is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,915.24 and is a delivery order with a firm fixed price. The contract provides for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication, to support military healthcare programs. The contract has no set-aside designation, indicating open competition....
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE8JT
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,234.77 firm fixed-price delivery order is for the procurement of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:06 PM